Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Sumitomo Dainippon Pharma Co (DNPUF) vs. Competitors

10 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DNPUFSumitomo Dainippon Pharma Co$11.90$5.33B17.77-8.50%Moderate BuyUnlock the DNPUF analyst price target with TipRanks PremiumDNPUFUnlock the DNPUF top-analyst price target with TipRanks Premium
JP:4523Eisai CoJPY 5,240.00JPY 1.48T33.8914.44%―Unlock the JP:4523 analyst price target with TipRanks PremiumDNPUF vs JP:4523Unlock the JP:4523 top-analyst price target with TipRanks Premium
JP:4547Kissei Pharmaceutical CoJPY 4,455.00JPY 181.97B16.555.69%HoldUnlock the JP:4547 analyst price target with TipRanks PremiumDNPUF vs JP:4547Unlock the JP:4547 top-analyst price target with TipRanks Premium
JP:4507Shionogi & CoJPY 3,175.00JPY 2.79T11.2217.33%Moderate BuyUnlock the JP:4507 analyst price target with TipRanks PremiumDNPUF vs JP:4507Unlock the JP:4507 top-analyst price target with TipRanks Premium
JP:4502Takeda Pharmaceutical CoJPY 6,869.00JPY 10.96T28.1858.05%Strong BuyUnlock the JP:4502 analyst price target with TipRanks PremiumDNPUF vs JP:4502Unlock the JP:4502 top-analyst price target with TipRanks Premium
JP:4516Nippon Shinyaku Co., Ltd.JPY 3,377.00JPY 227.45B7.69-4.20%HoldUnlock the JP:4516 analyst price target with TipRanks PremiumDNPUF vs JP:4516Unlock the JP:4516 top-analyst price target with TipRanks Premium

Performance Comparison

-50%-25%0%25%50%75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DNPUFSumitomo Dainippon Pharma Co11.89-1.11-8.50%
JP:4523Eisai Co5240.00696.7715.34%
JP:4547Kissei Pharmaceutical Co4455.00396.989.78%
JP:4507Shionogi & Co3175.00550.2020.96%
JP:4502Takeda Pharmaceutical Co6869.002609.0761.25%
JP:4516Nippon Shinyaku Co., Ltd.3377.00-138.05-3.93%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts